Premium Nahrungsergänzungsmittel | artgerecht

Exfoliation Glaucoma – Causes, Symptoms and Treatment

Exfoliation glaucoma is a form of glaucoma in which protein fiber deposits in the eye raise intraocular pressure, progressively damaging the optic nerve.

Regular tips about health Regular tips about health

Things worth knowing about "Exfoliation Glaucoma"

Exfoliation glaucoma is a form of glaucoma in which protein fiber deposits in the eye raise intraocular pressure, progressively damaging the optic nerve.

What is Exfoliation Glaucoma?

Exfoliation glaucoma – also known as pseudoexfoliation glaucoma or PEX glaucoma – is a specific type of glaucoma that develops as a complication of pseudoexfoliation syndrome (PEX syndrome). In this condition, a characteristic whitish-grey fibrillar material accumulates on the lens capsule and in the trabecular meshwork of the eye. This material obstructs the drainage of aqueous humor, leading to an increase in intraocular pressure (IOP). Over time, elevated IOP damages the optic nerve and can result in irreversible vision loss or blindness if left untreated.

Causes and Risk Factors

The exact cause of exfoliation glaucoma is not yet fully understood. A combination of genetic and environmental factors is believed to contribute.

Genetic predisposition: Variants in the LOXL1 gene – involved in connective tissue formation – are the most significant known genetic risk factor.
Age: The risk increases significantly with advancing age. The condition is rarely seen before age 60.
Geographic and ethnic factors: PEX syndrome is particularly prevalent in Scandinavia, the Mediterranean region, and certain Asian populations.
UV radiation: Increased sun exposure has been proposed as a potential environmental trigger.
Sex: Women appear to be slightly more affected than men.

Symptoms

Exfoliation glaucoma typically develops gradually and causes no noticeable symptoms in its early stages. Signs in more advanced disease include:

Visual field loss, often starting at the periphery
Blurred vision or reduced visual acuity
In acute pressure spikes: eye pain, headache, nausea, and halos around lights

Because the disease can remain silent for years, it is often diagnosed incidentally during a routine eye examination.

Diagnosis

Diagnosis is made by an ophthalmologist using a combination of tests:

Slit-lamp examination: Detection of characteristic fibrillar deposits on the lens and in the trabecular meshwork
Tonometry: Measurement of intraocular pressure
Gonioscopy: Evaluation of the drainage angle and identification of exfoliative material
Ophthalmoscopy: Assessment of the optic nerve head for glaucomatous damage (e.g., increased cup-to-disc ratio)
Perimetry (visual field testing): Detection of visual field defects
OCT (Optical Coherence Tomography): Structural imaging of the retinal nerve fiber layer

Treatment

The goal of treatment is to lower intraocular pressure and prevent further optic nerve damage. Exfoliation glaucoma often responds less predictably to therapy than primary open-angle glaucoma and may require more intensive management.

Medical Therapy

Treatment typically begins with pressure-lowering eye drops. Drug classes used include:

Prostaglandin analogues (e.g., latanoprost, bimatoprost): Increase aqueous outflow
Beta-blockers (e.g., timolol): Reduce aqueous humor production
Carbonic anhydrase inhibitors (e.g., dorzolamide): Decrease aqueous production
Alpha-2 agonists (e.g., brimonidine): Dual mechanism of action

Laser Treatment

Selective Laser Trabeculoplasty (SLT) can enhance aqueous drainage through the trabecular meshwork and effectively reduce IOP. It is considered a particularly valuable option in the management of exfoliation glaucoma.

Surgical Treatment

When medications and laser therapy are insufficient, surgical procedures may be considered:

Trabeculectomy: Creation of a new drainage pathway for aqueous humor
Minimally invasive glaucoma surgery (MIGS): Micro-incisional procedures with a lower risk profile

Prognosis and Follow-Up

Exfoliation glaucoma tends to follow a more aggressive course than primary open-angle glaucoma, with higher and more fluctuating IOP levels. Regular ophthalmological follow-up is therefore essential to monitor disease progression and adjust treatment. When diagnosed early and managed consistently, most patients can preserve functional vision in the long term.

References

European Glaucoma Society (EGS): Terminology and Guidelines for Glaucoma, 5th Edition, 2020. Available at: https://www.eugs.org
Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45(4):265-315. PubMed PMID: 11166364.
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. PubMed PMID: 24825645.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.